GlucoTrack, Inc.
GCTK
$0.1714
-$0.0026-1.49%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 5.05M | 3.57M | 2.91M | 2.56M | 2.40M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 14.55M | 13.11M | 12.08M | 8.77M | 7.10M |
Operating Income | -14.55M | -13.11M | -12.08M | -8.77M | -7.10M |
Income Before Tax | -22.60M | -14.92M | -12.05M | -8.74M | -7.10M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -22.60 | -14.92 | -12.05 | -8.74 | -7.10 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -22.60M | -14.92M | -12.05M | -8.74M | -7.10M |
EBIT | -14.55M | -13.11M | -12.08M | -8.77M | -7.10M |
EBITDA | -14.51M | -13.08M | -12.05M | -8.75M | -7.08M |
EPS Basic | -65.82 | -56.82 | -48.31 | -41.34 | -37.91 |
Normalized Basic EPS | -33.06 | -35.51 | -30.20 | -23.36 | -21.21 |
EPS Diluted | -65.82 | -56.82 | -48.31 | -41.34 | -37.91 |
Normalized Diluted EPS | -33.06 | -35.51 | -30.20 | -23.36 | -21.21 |
Average Basic Shares Outstanding | 1.32M | 1.03M | 982.50K | 924.30K | 829.70K |
Average Diluted Shares Outstanding | 1.32M | 1.03M | 982.50K | 924.30K | 829.70K |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |